244 related articles for article (PubMed ID: 38324228)
1. SPIONs: Superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancer.
Kara G; Ozpolat B
Biomed Microdevices; 2024 Feb; 26(1):16. PubMed ID: 38324228
[TBL] [Abstract][Full Text] [Related]
2. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
3. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
Revia RA; Stephen ZR; Zhang M
Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
[TBL] [Abstract][Full Text] [Related]
4. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy.
Zhi D; Yang T; Yang J; Fu S; Zhang S
Acta Biomater; 2020 Jan; 102():13-34. PubMed ID: 31759124
[TBL] [Abstract][Full Text] [Related]
5. Biotechnological approach to induce human fibroblast apoptosis using superparamagnetic iron oxide nanoparticles.
Ferraz FS; López JL; Lacerda SMSN; Procópio MS; Figueiredo AFA; Martins EMN; Guimarães PPG; Ladeira LO; Kitten GT; Dias FF; Domingues RZ; Costa GMJ
J Inorg Biochem; 2020 May; 206():111017. PubMed ID: 32120160
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
7. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
Kievit FM; Zhang M
Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865
[TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
9. RNAi-based therapeutics and tumor targeted delivery in cancer.
Kara G; Calin GA; Ozpolat B
Adv Drug Deliv Rev; 2022 Mar; 182():114113. PubMed ID: 35063535
[TBL] [Abstract][Full Text] [Related]
10. Increased cellular uptake of biocompatible superparamagnetic iron oxide nanoparticles into malignant cells by an external magnetic field.
Prijic S; Scancar J; Romih R; Cemazar M; Bregar VB; Znidarsic A; Sersa G
J Membr Biol; 2010 Jul; 236(1):167-79. PubMed ID: 20602230
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles.
Zolata H; Abbasi Davani F; Afarideh H
Nucl Med Biol; 2015 Feb; 42(2):164-70. PubMed ID: 25311750
[TBL] [Abstract][Full Text] [Related]
12. Galactomannan armed superparamagnetic iron oxide nanoparticles as a folate receptor targeted multi-functional theranostic agent in the management of cancer.
R S; M Joseph M; Sen A; K RP; Bs U; Tt S
Int J Biol Macromol; 2022 Oct; 219():740-753. PubMed ID: 35907463
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic Iron-Oxide Nanoparticles Synthesized via Green Chemistry for the Potential Treatment of Breast Cancer.
Tyagi N; Gupta P; Khan Z; Neupane YR; Mangla B; Mehra N; Ralli T; Alhalmi A; Ali A; Al Kamaly O; Saleh A; Nasr FA; Kohli K
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903587
[TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic iron oxide based nanoprobes for imaging and theranostics.
Lam T; Pouliot P; Avti PK; Lesage F; Kakkar AK
Adv Colloid Interface Sci; 2013 Nov; 199-200():95-113. PubMed ID: 23891347
[TBL] [Abstract][Full Text] [Related]
15. A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model.
Klapproth AP; Shevtsov M; Stangl S; Li WB; Multhoff G
Int J Nanomedicine; 2020; 15():4677-4689. PubMed ID: 32669844
[TBL] [Abstract][Full Text] [Related]
16. Heparin-Superparamagnetic Iron Oxide Nanoparticles for Theranostic Applications.
Massironi N; Colombo M; Cosentino C; Fiandra L; Mauri M; Kayal Y; Testa F; Torri G; Urso E; Vismara E; Vlodavsky I
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296711
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Superparamagnetic Iron Oxide Based Nanoprobes as Multifunctional Theranostic Agents for Breast Cancer Imaging and Therapy.
Zheng J; Ren W; Chen T; Jin Y; Li A; Yan K; Wu Y; Wu A
Curr Med Chem; 2018; 25(25):3001-3016. PubMed ID: 28685676
[TBL] [Abstract][Full Text] [Related]
18. Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges.
Bakhtiary Z; Saei AA; Hajipour MJ; Raoufi M; Vermesh O; Mahmoudi M
Nanomedicine; 2016 Feb; 12(2):287-307. PubMed ID: 26707817
[TBL] [Abstract][Full Text] [Related]
19. Iron oxide nanoparticles for targeted cancer imaging and diagnostics.
Rosen JE; Chan L; Shieh DB; Gu FX
Nanomedicine; 2012 Apr; 8(3):275-90. PubMed ID: 21930108
[TBL] [Abstract][Full Text] [Related]
20. Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles.
Gui G; Fan Z; Ning Y; Yuan C; Zhang B; Xu Q
Int J Nanomedicine; 2021; 16():2283-2295. PubMed ID: 33776433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]